New York City’s oldest Department of Neurology, we opened our inpatient service in 1900. For more than a century, we have contributed to clinical and scientific research, trained generations of neurologists, and held prominent positions on the national and international neurological stage. Here are a few highlights of our history:
Bernard Sachs, MD, published the first description in United States of amaurotic familial idiocy, later known as Tay-Sachs disease.
Opened the Neurology Clinic in the Dispensary on 67th Street.
Bernard Sachs, MD, became editor of the Journal of Nervous and Mental Diseases.
Bernard Sachs, MD, was named president of the American Neurological Association.
Established the in-patient neurological service, the first in a New York hospital.
Dedicated our first neurological ward.
Israel Straus, MD, and Joseph Globus, MD, described a brain tumor they call "spongioblastoma."
Leo Loewe, MD, and Israel Strauss, MD, described the first experimental transmission of encephalitis lethargica.
Created neuropathology laboratory.
Developed residency program in neurology.
Established electroencephalographic unit.
Morris B. Bender, MD, classified what he called “transient circulatory disturbance of the brain,” which came to be known as transient global ischemia.
Division of Clinical Neurophysiology created.
Neurochemistry Lab opened.
Created clinic for the study and treatment of Parkinson's disease and other extrapyramidal disorders.
Neurovirology lab created.
Melvin D. Yahr, MD, published a study showing L-dopa is an effective treatment for Parkinson’s disease.
Established a clinical center for Parkinson's disease.
Opened first U.S. clinic for patients with Amyotrophic Lateral Sclerosis (Lou Gehrig's disease)
Gustave L. Levy Stroke Unit opened.
After Dr. Yahr's retirement in 1991, Howard Lipton was appointed Chairman and Goldschmidt Professor. Dr. Lipton was followed by C. Warren Olanow in 1994. Dr. Olanow is a world-renowned expert in Parkinson’s disease whose contributions have included fetal-nigral transplantation, the iron-infusion model of Parkinsonism, and deep brain stimulation. In 1996, the Neuroscience and Restorative Care Center was opened in the new Guggenheim Pavilion of the Hospital, enabling further integration of rehabilitation, neurosurgery, and neurology disciplines in the care of patients.
Opened the Neuroscience and Restorative Care Center for patient care.
Founded in 2001 and led by Dr. Fred D. Lublin, an international authority on MS, Mount Sinai's Corinne Goldsmith Dickinson Center for Multiple Sclerosis continues to make significant contribution to our understanding of the disease. As the recipient of $30 million NIH grant - the largest clinical grant ever given by the NIH - the MS center is involved in groundbreaking research efforts, including CombiRx, which is the first study to assess the effectiveness of combining two FDA approved medications as the initial treatment for people with Relapsing Remitting Multiple Sclerosis.
Became a New York State Department of Health-designated stroke center.
Created the multidisciplinary Neuro-Oncology program.
Mount Sinai Stroke Center earned the Joint Commission certification as a Primary Stroke Center, the first and only hospital in Manhattan to do so.
In 2008, the Friedman Brain Institute was established with Neurology as one of its participating Departments. The FBI focuses on various translational research programs such as Neural Injury and Repair, Cognition, and Neuropsychiatry. The FBI is directed by Eric Nestler, MD, PhD, Dean for Academic and Scientific Affairs.
Stuart Sealfon, MD, determined that LSD mirrors symptoms and chemical activity of schizophrenia.
Created a center for headache and pain medicine.
Became the first hospital in New York State to receive Joint Commission Comprehensive Stroke Center Certification.
Neurology/Neurosurgery ranked No. 14 in U.S. by U.S. News & World Report.
Barbara Vickrey, MD, MPH, is the most recent faculty member named President of the American Neurological Association